Top Markets
Coin of the day
Pharmigene, Inc. Pharmigene, Inc.

Pharmigene, Inc.

7595
Kedudukan dalam Saham #31884
Pharmigene, Inc. operates globally, specializing in the creation, production,... Pharmigene, Inc. operates globally, specializing in the creation, production, and distribution of diagnostic testing solutions. Its offerings include molecular diagnostic tools specifically designed to detect adverse drug reactions, alongside DNA extraction products crucial for diverse applications such as gene expression analysis, clinical molecular diagnostics, human identity verification, forensic investigations, and biomedical research. The firm also provides an array of specialized services, including pharmacogenomics, drug allergy screening, and functional medicine assessments. Beyond its own products, Pharmigene distributes various genomics and genetics equipment and reagents. Complementing these, it offers a comprehensive suite of support solutions, encompassing expert consultation, training programs, analytical software, and technical assistance. Furthermore, the company extends its capabilities through Contract Development and Manufacturing Organization (CDMO) services. Pharmigene, founded in 1994, is headquartered in Taipei, Taiwan.
Harga Saham
$0.23372286
Modal Pasaran
$11.79M
Perubahan (1 hari)
-0.14%
Perubahan (1 tahun)
-36.99%
Negara
TW
Perdagangan Pharmigene, Inc. (7595)

Kategori

Pendapatan untuk Pharmigene, Inc. (7595)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Pharmigene, Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Pharmigene, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa